Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.65p
   
  • Change Today:
    -0.050p
  • 52 Week High: 5.34p
  • 52 Week Low: 1.23p
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 1,781,827
  • Market Cap: £27.60m
  • Beta: 0.10

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-24 Interim 12.13 (15.48) (0.02)¢ n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.91) (10.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 5.50 (49.43) (21.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 13.09 (32.38) (5.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 24.54 (18.12) (2.90)p n/a n/a n/a n/a 0.0%
31-Dec-25 46.05 (7.54) (30.15)p n/a n/a n/a n/a 0.0%
31-Dec-26 63.87 0.51 (18.53)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 2.65p
Change Today -0.050p
% Change -1.85 %
52 Week High 5.34p
52 Week Low 1.23p
Volume 1,781,827
Shares Issued 1,041.69m
Market Cap £27.60m
Beta 0.10

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.27% below the market average40.27% below the market average40.27% below the market average40.27% below the market average40.27% below the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average
Price Trend
18.61% below the market average18.61% below the market average18.61% below the market average18.61% below the market average18.61% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Income Not Available
Growth
63.71% above the market average63.71% above the market average63.71% above the market average63.71% above the market average63.71% above the market average
74.19% above the sector average74.19% above the sector average74.19% above the sector average74.19% above the sector average74.19% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 07-Apr-2025

Time Volume / Share Price
15:50 38,170 @ 2.63p
13:05 114 @ 2.70p
13:05 60 @ 2.60p
13:05 156,093 @ 2.69p
12:47 264,150 @ 2.65p

STX Key Personnel

CEO Anders Lundstrom

Top of Page